Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 8, 2008, Pages 948-951

  Reuter, I ^a   Tai, Y F ^b   Pavese, N ^b   Chaudhuri, K R ^a   Mason, S ^c   Polkey, C E ^a   Clough, C ^a   Brooks, D J ^b   Barker, R A ^c   Piccini, P ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN A; DOPAMINE 2 RECEPTOR; RACLOPRIDE C 11; REBOXETINE; TUBERCULOSTATIC AGENT; ADRENERGIC RECEPTOR AFFECTING AGENT; CARBON; CYCLOSPORIN; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; IMMUNOSUPPRESSIVE AGENT; MORPHOLINE DERIVATIVE; RACLOPRIDE;

ALLOGRAFT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FETAL STRIATAL ALLOGRAFT; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; NEUROPSYCHOLOGICAL TEST; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; SURVIVAL TIME; TISSUE PREPARATION; ADULT; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; BRAIN EDEMA; BRAIN TRANSPLANTATION; CASE CONTROL STUDY; CAUDATE NUCLEUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORPUS STRIATUM; FETAL TISSUE TRANSPLANTATION; FOLLOW UP; LYMPHOCYTOSIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEUROLOGIC EXAMINATION; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRENATAL DEVELOPMENT; PUTAMEN; SCINTISCANNING; STEREOTACTIC PROCEDURE; TRANSPLANTATION;

ADRENERGIC UPTAKE INHIBITORS; ADULT; BRAIN EDEMA; BRAIN TISSUE TRANSPLANTATION; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; COMBINED MODALITY THERAPY; CORPUS STRIATUM; CYCLOSPORINE; DOPAMINE ANTAGONISTS; FEMALE; FETAL TISSUE TRANSPLANTATION; FOLLOW-UP STUDIES; HUMANS; HUNTINGTON DISEASE; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTOSIS; MALE; MIDDLE AGED; MORPHOLINES; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; PUTAMEN; RACLOPRIDE; STEREOTAXIC TECHNIQUES; TISSUE SURVIVAL;

EID: 48249145755     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.142380     Document Type: Article

References (11)

1. Kendall AL, Rayment FD. Torres EM, et al. Functional integration of striatal allografts in a primate model of Huntington's disease. Nat Med 1998;4:727-9.
2. Palfi S, Conde F, Riche D, et al. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat Med 1998;4:963-6.
3. Bachoud-Levi AC, Gaura V, Brugieres P, et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 2006;5:303-9.
4. Furtado S, Sossi V, Hauser RA, et al. Positron emission tomography after fetal transplantation in Huntington's disease. Ann Neurol 2005;58:331-7.
5. Freeman TB, Cicchetti F, Hauser RA, et al. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A 2000;97:13877-82.
6. Quinn N, Brown R, Craufurd D, et al. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Mov Disord 1996;11:143-50.
7. Fricker RA, Torres EM, Hume SP, et al. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 1997;79:711-21.
8. Pavese N, Andrews TC, Brooks DJ, et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain 2003;126(Pt 5):1127-35.
9. Krystkowiak P, Gaura V, Labalette M, et al. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS One 2007;2:e166.
10. Piccini P, Lindvall O, Bjorklund A, et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 2000;48:689-95.
11. Peschanski M, Bachoud-Levi AC, Hantraye P. Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain 2004;127(Pt 6):1219-28.